Actively Recruiting
Immunonutrition and Tolerance to Chemoradiotherapy in Patients With Head-neck Cancer
Led by Fondazione IRCCS Policlinico San Matteo di Pavia · Updated on 2025-05-01
86
Participants Needed
1
Research Sites
295 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of the present project is to evaluate in a randomised, controlled, open-label, two parallel treatment groups pilot study, the efficacy of oral nutritional supplementation with a high-protein-high calorie mixture containing immunonutrients compared to a standard high-calorie-high-protein nutritional blend, in addition to nutritional counseling, in improving tolerance to chemoradiotherapy (CT-RT) in patients with tumours of the head and neck
CONDITIONS
Official Title
Immunonutrition and Tolerance to Chemoradiotherapy in Patients With Head-neck Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of head-neck cancer
- Planned curative or adjuvant chemoradiotherapy
- Willingness to participate in planned measurements and provide written informed consent
You will not qualify if you...
- Younger than 18 years
- Currently receiving or planned for artificial nutrition
- Refusal to participate
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fondazione IRCCS Policlinico San Matteo
Pavia, Italy, 27100
Actively Recruiting
Research Team
R
Riccardo Caccialanza, MD
CONTACT
E
Emanuele Cereda, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here